EASL Policy Dialogues S2 E5: Rare but not forgotten – The challenges of living with PBC

EASL Studio Podcast S5 E1: What is really new in the EASL CPG on ACLF?

EASL Studio S5 E1: What is really new in the EASL CPG on ACLF?

EASL Studio Podcast: Practice changing highlights from EASL Congress 2023

EASL Studio Podcast: EASL Congress 2023: Back to the future

EASL Studio Podcast: Highlights of liver cancer research at EASL Congress 2023

EASL Studio Podcast: United we stand: Global societies collaborating to beat liver disease

EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

EASL Studio Podcast S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

EASL Studio S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

EASL Studio S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

EASL Studio Podcast S4 E21: Why you should stop smoking if you love your liver

EASL Studio S4 E21: Why you should stop smoking if you love your liver

EASL Studio Podcast S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

EASL Studio S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

EASL Studio S4 Special Edition: Promoting Liver Health: An urgent call for action at WHO

EASL Studio Podcast S4 Special Edition: Promoting Liver Health: An urgent call for action at WHO

EASL Studio S4 E19: HDV: The devil becomes treatable